Barclays Lifts Crocs to Overweight as Shares Gain About 6%

what happened

Crocs stock climbed roughly 7% in the afternoon session after Barclays swapped its Equal Weight call for Overweight and raised its price target to $139 from $118, StockStory.org reported. Analyst Adrienne Yih told StreetInsider that the company's path toward sustained expansion has become clearer. Crocs International is already expanding, Crocs North America has returned to growth in the second quarter, and she anticipates HEYDUDE will follow in the second half. In her view, the business has moved beyond stabilization and entered the initial phase of a steadier growth period.

Yih also pointed to newer product lines beyond the Classic Clog as key sellers, with management expecting sandals to approach $500 million in yearly sales. Promotional discounts were reduced, a move that has weighed on near-term revenue but pushed more sales to full price. She described international expansion as underappreciated: the brand remains early in China, India, Japan and Western Europe, and international sales account for about 49% of Crocs brand revenue. Barclays lifted its fiscal 2028 adjusted earnings estimate to $15.49 and applied a nine-times multiple to the $139 target. Ending the session at $124.73, the stock was 6.1% higher than the previous day's close.

why it matters

The note shifts the valuation debate, since the analyst argues investors can focus on earnings growth rather than turnaround risk, as StockStory.org reports. The shares remain volatile, with 17 moves greater than 5% over the past year, and they still sit 11.6% below their 52-week high of $141.19 set in August 2026. Year to date the stock is up 43.5%.

tags

instruments